Philips CPAP class action settlement provides reimbursements for individuals with recalled sleep apnea devices, but does not impact any pending personal injury claims for health issues caused by toxic foam inside the machines.
In some cases, nursing home patients on ventilators were several times more likely to develop treatment-resistant infections than those on ventilators in hospitals.
The FDA warns that the recalled Hamilton ventilators may fail and stop providing potentially life-saving air therapy support to patients due to design problem.
Philips' CEO has indicated a desire to reach a CPAP machine personal injury lawsuit settlement sometime next year, at a cost many expect will far exceed the $479 million paying in a class action settlement recently announced.
At least 80 complaints involving ventilator failures have been reported in relation to faulty software that prompted a recall for about 12,429 Hamilton ventilators
The FDA warns that the recalled Draeger Carina ventilators contain toxic sound abatement foam which could put patients at an increased risk of cancer and death.
This is the latest in a string of Philips CPAP and ventilators recalls over the last several years, with most involving toxic sound abatement foam.
Recalled Dräger ventilators contain PE-PUR sound insulation foam that could release toxic gases, causing similar problems linked to a massive Philips CPAP recall issued more than two years ago.
An air flow sensor in the recalled Philips Trilogy Evo, Garbin Evo, and Aeris EVO ventilators may not detect the build-up of debris in the devices, which could lead to low blood oxygen, serious injuries and death.
Supposedly repaired Trilogy and Garbin Plus Ventilators may experience silicone foam adhesive failure, which could lead to airpaths being blocked, putting ventilator patients at risk.
